Article
31 May 2024
Anti-Obesity Medications: Noteworthy Developments As Policymakers Weigh Coverage Considerations
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
24 Nov 2023
Recent FTC Merger Settlement Signals Increased Antitrust Agency Concerns About Coordination From Competitor Entanglements
Article
31 Jul 2023
The Agencies Release Consolidated Merger Guidelines: Insights From The Latest Signal For Expanded Merger Enforcement
Article
13 Jul 2023
From Private Equity Ownership To PBMs And Drug Pricing: Congress Scrutinizes The Health Care Industry
Article
13 Jul 2023
Antitrust Agencies' Proposed Changes To The HSR Form Will Dramatically Increase The Burden On Filers
Article
09 May 2023
SCOTUS Decision Sets Up Constitutional Challenges To FTC Administrative Proceedings
Article
02 Mar 2023
Congress Urges FTC Scrutiny Of The Life Sciences Industry: Will This Be A New Chapter In The Administration's Drug Pricing Playbook?
Article
26 Jan 2023
FTC Updates HSR Filing Fees And Revises Thresholds For 2023; Minimum Size For Reportable Transactions Increases To $111.4 Million
Article
20 Jan 2023
The Drug Pricing Drumbeat Continues: IRA Update And Key Areas To Watch In 2023
Article
06 Jan 2023
New HSR Filing Fee Structure For 2023
